Cardiome Pharma Corp (NASDAQ:CRME)

Delayed Data
As of Apr 20
 -0.05 / -2.14%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 5.00, with a high estimate of 9.50 and a low estimate of 3.30. The median estimate represents a +118.34% increase from the last price of 2.29.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.36%
Growthannually 31.61%


Growthquarterly 3.70%
Growthannually 32.78%
Key to the earnings and sales forecast charts.